Contract manufacturing at a crossroads: The way forward
Description Amid surging pandemic consumer demand and an expanding number of inquiries, contract manufacturing has reached a critical juncture. Large-scale supplement makers are wrestling with investment decisions about adding capacity in response, just as ingredient prices remain remarkably high, and supply chains are tightening. Savvy brands recognize the contract manufacturing factors in flux and are shaping new protocols around them.
This session will cover:
New calls for transparency and the advent of cGMP (current good manufacturing practice) requirements by Amazon and other retailers.
Virtual audits and visits, and whether they are here to stay.
Lessons learned from recent recalls and long-term effects on the industry.
Viability of just-in-time inventories and the difficulties in broadening sources of supply.
Underwritten by: